The Tycoon Report
More Bang for Your Buck: The stock you want to own is …
Friday, June 23, 2006 | Jason Jovine

I spoke with a wonderful lady not too long ago who was telling me about a stock that she was looking to buy, but that she couldn’t, because the price just kept going higher and higher each day.

She told me that it was recommended by one of our Tycoon family members here and she wasn’t sure what to do. Finally she told me about the recommendation, and I informed her that I (Jason Jovine) was the one who recommended that investment.

She had thought that one of my colleagues here at Tycoon had made the recommendation. That was bittersweet, because while I was happy to hear that she was a follower, it was a little unsettling to know that she was not sure who she was following.

Either way, she was my impetus for informing all of you that it is VERY important to know who is writing each article, because we are all different and each one of my colleagues are great in their own right.

For those of you who have written in to ask, I usually write for The Tycoon Report once per week. I submit my “article” on Thursdays, and it gets sent out to you all on Fridays. That said, if I recommend something, let’s say today, and it goes out tomorrow, and then on Monday some big news happens with the company … I can’t tell you how to handle it until next time I write.

I can still give you great ideas, but I can’t guide you as much as I would like and as much as I’m sure you would like unless I have my own newsletter. If that were the case, I would keep you abreast of how to handle a situation from the initial purchase until the time we take a profit. Do you follow me?

Take a look at this stock ...

I like Bio-Reference Laboratories here. The symbol for this stock is BRLI. This stock trades on NASDAQ NM. When you read this report, the stock should be at about $21 or $22 per share.

Bio-Reference Laboratories, Inc. (Bio-Reference) is an independent regional clinical laboratory servicing the greater New York metropolitan area.

I live in this area and am familiar with the situation; thus, I really like the company and I love the stock at these prices.

Until the next time folks, take care of yourself and each other ...



(Please let us know what you think about Jason Jovine's article.)
Rate his article here »



Jason Jovine
Chief Investment Officer
<>